Form 4: TPG GP A, LLC, David Bonderman, James G. Coulter, and Jon Winkelried Report Changes in Beneficial Ownership of Bicara Therapeutics Inc. Following IPO
SEC Form 4
TPG GP A, LLC, along with David Bonderman, James G. Coulter, and Jon Winkelried, reported changes in their beneficial ownership of Bicara Therapeutics Inc. common stock following the company's initial public offering.
Summary
- TPG GP A, LLC, David Bonderman, James G. Coulter, and Jon Winkelried filed a Form 4 to report changes in their beneficial ownership of Bicara Therapeutics Inc. (BCAX) common stock.
- The report indicates that 18,121,194 shares of Series C Preferred Stock held by TPG LSI Rise Butterfly, L.P. automatically converted into 1,960,425 shares of common stock upon the consummation of Bicara Therapeutics Inc.'s initial public offering on September 16, 2024.
- The reporting persons may be deemed to beneficially own the securities reported to the extent of their pecuniary interests in TPG LSI Rise Butterfly, L.P.
- The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction following an IPO. The sentiment is neutral as it simply reports changes in ownership.
Industry Context
This filing is a standard procedure following an IPO, as significant shareholders adjust their holdings and report changes in beneficial ownership to the SEC.
Stakeholder Impact
- The conversion of preferred stock to common stock impacts shareholders by increasing the number of outstanding common shares.
- This filing provides transparency to the market regarding the ownership structure of Bicara Therapeutics Inc.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | 1-for-9.2435 reverse stock split effected |
| 09/16/2024 | Date of earliest transaction and consummation of Bicara Therapeutics Inc.'s initial public offering, resulting in the conversion of Series C Preferred Stock to Common Stock. |
| 09/18/2024 | Date of signatures for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.